Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus

British Journal of Rheumatology

Volumn 36, Issue 1, 1997, Pages 32-37

  Gunnarsson, I ^a   Ronnelid J ^a   Huang, Y H ^a   Rogberg, S ^a   Nilsson, B ^b   Lundberg, I ^a   Klareskog, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anti C1q antibodies; Nephritis; SLE

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY BIOPSY; MALE; MONONUCLEAR CELL; NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030810937     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.1.32     Document Type: Article

References (17)

1. Woods VL. Pathogenesis of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders Company, 1993:999-1016.
2. Bowness P, Davies KA, Norsworthy PJ et al. Hereditary Clq deficiency and systemic lupus erythematosus. Q J Med 1994;87:455-64.
3. Coremans IEM. Pathogenetic mechanisms of anticomplement antibodies autoimmune disease. Thesis, Leiden, 1995.
4. Wener MH, Uwatoko S, Mannik M. Antibodies to the collagen-like region of Clq in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 1989;32:544-51.
5. Siegert CEH, Daha M, Westedt M-L, van der Voort E, Breedveld F. IgG autoantibodies against Clq are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991;18:230-4.
6. Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against Clq for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993;52:851-6.
7. Czerkinsky CC, Nilsson L-Å, Nygren H, Ouchterlony Ö, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983;65:109-21.
8. Rönnelid J, Huang YH, Norrlander T et al. Short-term kinetics of the humoral anti-Clq response in SLE using the ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 1994;40:243-50.
9. Swaak AJG, Aarden LA, Statius van Eps LW, Feltkamp TEW. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979;22:226-35.
10. Lloyd W, Schur PH. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981;60:208-17.
11. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990;33:634-43.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
14. Siegert CEH, Daha MR, van der Voort EAM, Breedveld FC. IgG and IgA antibodies to the collagen-like region of Clq in rheumatoid vasculitits. Arthritis Rheum 1990;33:1646-54.
15. Churg J, Sobin LH. Renal disease, classification and atlas of glomerular diseases. Tokyo/New York: Igaku-Shoin, 1982.
16. Heinz H-P, Burger R, Golan MD, Loos M. Activation of the first component of complement, Cl, by a monoclonal antibody recognizing the C chain of Clq. J Immunol 1984;132:804-8.
17. Heinz H-P, Rubin K, Laurell A-B, Loos M. Common epitopes in Clq and collagen type II. Mol Immunol 1989;26:1-63-9.